Global Cervical Cancer Diagnostic Tests Market Research Report 2014-2018

Global Cervical Cancer Diagnostic Tests Market 2014-2018 is the latest addition to industry research reports collection.

Cervical cancer diagnostic tests are used to identify the presence of the precancerous or cancerous lesions in the cervix of a woman. These tests include an initial screening using pap smear and HPV testing, and upon positive results, colposcopy and biopsy are further utilized to confirm the diagnosis. After the positive diagnosis, the patient is further subjected to imaging tests that are used to establish the grade of cancer.

Analysts forecast the Global Cervical Cancer Diagnostic Tests market to grow at a CAGR of 10.89 percent over the period 2013-2018.

Single User License of the report is Available at US $2500

Covered in this Report

The report covers the present scenario and the growth prospects of the Global Cervical Cancer Diagnostic Tests market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following diagnostic test kits and instruments used to diagnose cervical cancer:

  • Pap Smear Test
  • HPV Testing
  • Colposcopy
  • Biopsy

In addition, the report includes the type of method used to identify cervical cancer:

  • Molecular method
  • Cytopathological method
  • Physical method

Technological types used in cervical cancer identification are also discussed in this report:

  • FISH
  • PCR
  • Staining & Microscopy
  • Optical Imaging

Global Cervical Cancer Diagnostic Tests Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Cervical Cancer Diagnostic Tests market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Order a copy of this report at (Prices start at US $2500 for a single user PDF) .

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Abbott Laboratories
  • Becton Dickinson
  • Hologic
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics

Other Prominent Vendors

  • Anthera Pharmaceuticals
  • Arbor Vita
  • Autogenomics
  • Biolight Meditech
  • BioMerieux
  • Biovantra
  • Cancer Genetics
  • Cervia Diagnostics
  • Centrel
  • Cooper Surgical
  • Cytoimmun
  • DySIS Medical
  • Edan
  • Femasys
  • Greiner Bio One
  • Guided Therapeutics
  • Incell dx
  • Innogenetics
  • Kernel Medical
  • Lutech Industries
  • Medgyn
  • Micromedic Technologies
  • Norchip
  • Olympus Medical
  • OncoHealth Corp
  • Optomic
  • Optopol Technology
  • Shenzhen Goldcare Meditech
  • Sunray
  • Zilico

Market Driver

  • Increased Incidence of Smoking

Market Challenge

  • Lack of Awareness

Market Trend

  • Development of New Diagnostic Platforms

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Have any Query on the Report get your Queries Resolved at .

End of Year Discounts: A discount of 20% on all reports by Infiniti Research Limited, published until the 24th of September 2014. Discount available till 15th January 2015.

About US: ( is an online market research store for research reports on multiple industries. These reports provide market analysis, trends and opportunities and forecast about industries that helps to make a right decision for the business.